Sandro Pasquali
@sandro_pasquali
Clinician scientist at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
ID:1278798654
18-03-2013 21:38:43
2,6K Tweets
682 Followers
662 Following
Honored to have joined Istituto Tumori with Nadia Zaffaroni and Sandro Pasquali for a few months of research in #sarcoma . Thanks Universidad de Castilla-La Mancha for the chance to keep our research abroad and improve our experimental models.
We close out Day 3 of #SPAGN2024 with a fascinating conversation on AI. Maria Brandt of Deutsche Sarkom-Stiftung talked about using ChatGPT & AI assisted tools to save time creating content & increase your reach. And Dr. Sandro Pasquali spoke about using AI to support #sarcoma research.
Brilliant summary of cellular therapy at #ISG
🌟 Lecture of Dr. Ignazio Caruana from University Children's Hospital of Wurzburg, on its use in #sarcomas shines a light of hope for the future of these tumors treatment.
Alessandra Merlini
La coordinazione tra medici e associazioni Pazienti può portare ad aprire tavoli di lavoro con le istituzioni e la giornata di oggi ne è la prova! Italian Sarcoma Group Associazione EHE ITALIA ODV Desmoid Foundation ONLUS - Italia #sarcoma
⚔️ Exciting discussion during the second battle at #ISG annual meeting on the benefits and drawbacks of dose dense chemotherapy in Ewing Sarcoma!!
↔️ Different viewpoints brought to light the complexities of this treatment approach!!
#ewingsarcoma #dosedense #chemotherapy
The second day of #ISG annual meeting kicks off with an interesting educational session on #bone sarcomas.
👥 Collaboration between pediatric and adult oncologists is crucial for comprehensive care across all ages!!
#bone sarcoma Emanuela Palmerini Silvia Stacchiotti
After the pre-meeting sessions clinical study coordinators and patients advocates led, the official opening of the annual meeting is going live. Our predident Silvia Stacchiotti gives her overview of the Italian Sarcoma Group activities of the past 3 years during her presidency
Excellent talk from Prof Paolo G Casali on the controversial world of surrogate endpoints in clinical research today!!
📌 Are they reliable indicators of treatment efficacy or just a shortcut?
Great debate at #ISG annual meeting ✔️
#sarcoma Alessandro Gronchi
antonella brunello Rosalba Miceli
Today the #departmentbreakfast Istituto Tumori is about #retroperitoneal #sarcoma ❕Incidence of about 0.5/100k/yr, 80 new #patients with primary RPS resected each year in #Milan . Does volume help moving the needle?
#Postdoc position available on #sarcoma #Immunity at Molecular Pharmacology of Istituto Tumori - if interested please contact [email protected]
At the cutting edge of sarcoma/gist/desmoid management and research! Marco Fiore, MD, FACS, FEBSh Stefano Radaelli Dario Callegaro Sandro Pasquali Italian Sarcoma Group EORTC CTOS Society of Surgical Oncology European Society of Surgical Oncology (ESSO) AnnalsSurgOncology European Journal of Surgical Oncology